Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine

Por Marashly, Eyad T., Bohlega, Saeed A.
Publicado no Front Neurol (2017)

Clinical and Molecular Characterization of Ataxia with Oculomotor Apraxia Patients In Saudi Arabia

Por Bohlega, Saeed A, Shinwari, Jameela M, Al Sharif, Latifa J, Khalil, Dania S, Alkhairallah, Thamer S, Al Tassan, Nada A
Publicado em 2011

Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries

Por Aljumah, Mohammed, Alroughani, Raed, Alsharoqi, I., Bohlega, Saeed A., Dahdaleh, Maurice, Deleu, Dirk, Esmat, Khaled, Khalifa, Ahmad, Sahraian, Mohammad A., Szólics, Miklós, AlTahan, Abdulrahman, Yamout, Bassem I., Rieckmann, Peter, Daif, Abdulkader
Publicado em 2013

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring

Por Alroughani, Raed A, Aref, Hany M, Bohlega, Saeed A, Dahdaleh, Maurice P, Feki, Imed, Al Jumah, Mohammed A, Al-Kawi, Muhammad Z, Koussa, Salam F, Sahraian, Mohamad A, Alsharoqi, Isa A, Yamout, Bassem I
Publicado em 2014

Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families

Por Bohlega, Saeed A., Al-Mubarak, Bashayer R., Alyemni, Eman A., Abouelhoda, Mohamed, Monies, Dorota, Mustafa, Abeer E., Khalil, Dania S., Al Haibi, Sara, Abou Al-Shaar, Hussam, Faquih, Tariq, El-Kalioby, Mohamed, Tahir, Asma I., Al Tassan, Nada A.
Publicado no BMC Res Notes (2016)

Parkinson’s Disease in Saudi Patients: A Genetic Study

Por Al-Mubarak, Bashayer R., Bohlega, Saeed A., Alkhairallah, Thamer S., Magrashi, Amna I., AlTurki, Maha I., Khalil, Dania S., AlAbdulaziz, Basma S., Abou Al-Shaar, Hussam, Mustafa, Abeer E., Alyemni, Eman A., Alsaffar, Bashayer A., Tahir, Asma I., Al Tassan, Nada A.
Publicado no PLoS One (2015)